Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma

被引:54
作者
Bandoh, N [1 ]
Hayashi, T [1 ]
Kishibe, K [1 ]
Takahara, M [1 ]
Imada, M [1 ]
Nonaka, S [1 ]
Harabuchi, Y [1 ]
机构
[1] Asahikawa Med Coll, Dept Otolaryngol, Asahikawa, Hokkaido 0788510, Japan
关键词
maxillary sinus carcinoma; p53; mutation; Fas; bax; bcl-x; apoptosis index; effectiveness of radiochemotherapy; prognostic factor;
D O I
10.1002/cncr.10388
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Many researchers have attempted to correlate p53 mutation and spontaneous apoptosis with the effectiveness of radio chemotherapy and with prognosis in several malignancies. METHODS. The current study group consisted of 70 Japanese patients with maxillary sinus squamous cell carcinoma (SCC). Fifty seven patients were treated with radio chemotherapy followed by total or partial maxillectomy, and the remaining13 patients were treated with radiotherapy alone. Tumor biopsy specimens at pretreatment status were examined for apoptosis-related proteins such as p53 protein, Fas, bax, bcl-x, and apoptosis using immunohistologic methods. The proportion of apoptotic cells labeled by single stranded DNA antibody was expressed as an apoptotic index (AI). p53 mutations at exons 5 through 8 were analyzed by direct sequence on polymerase chain reaction amplified products obtained from laser microdissected tissues. The effectiveness of radio chemotherapy was investigated histologically on surgically dissected specimens. RESULTS. p53 mutations were identified in 20 (29%) of 70 patients. p53 protein was overexpressed in 39 patients (56%), Fas in 20 patients (29%), bax in 40 patients (57%), and bcl-x in 33 patients (47%). Overexpression of bax was associated with negativity of bcl-x (P = 0.015) and with high AI (P = 0.024). Low AI and/or p53 mutation in the pretreatment tissues correlated with low histologic effectiveness of radiochemotherapy (P = 0.048, P = 0.019, respectively). Kaplan-Meier analysis as well as univariate analysis using the Cox proportional hazards model showed that low histologic effectiveness of radio chemotherapy (P = 0.0281, P = 0.0284, respectively), p53 mutations (P = 0.0095, P = 0.0187, respectively), negativity of bax (P = 0.0069, P = 0.0191, respectively), and low AI (P = 0.0134, P = 0.0407, respectively) were significantly related to worse disease-free survival. Multivariate analysis showed Al as an independent factor predicting for disease-free survival (P = 0.0455). CONCLUSIONS. The p53 mutations, expression of bax, and levels of spontaneous apoptosis have prognostic value in maxillary sinus SCC; AI especially is an independent factor for disease-free survival. A high level of spontaneous apoptosis induced by overexpression of bax may increase sensitivity of radio chemotherapy resulting in good prognosis, while p53 mutation may lead to resistance against radiochemotherapy. resulting in poor prognosis.
引用
收藏
页码:1968 / 1980
页数:13
相关论文
共 79 条
  • [21] Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer
    Hotz, MA
    Bosq, J
    Zbaeren, P
    Reed, J
    Schwab, G
    Krajewski, S
    Brousset, P
    Borner, MM
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (04) : 417 - 422
  • [22] Decreased expression of Bar is correlated with poor prognosis in oral and oropharyngeal carcinoma
    Ito, T
    Fujieda, S
    Tsuzuki, H
    Sunaga, H
    Fan, GK
    Sugimoto, C
    Fukuda, M
    Saito, H
    [J]. CANCER LETTERS, 1999, 140 (1-2) : 81 - 91
  • [23] Izawa Hidemi, 1999, Auris Nasus Larynx, V26, P317, DOI 10.1016/S0385-8146(99)00005-X
  • [24] Jäckel MC, 1999, CANCER-AM CANCER SOC, V85, P591
  • [25] Jäckel MC, 2000, LARYNGOSCOPE, V110, P1339
  • [26] Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer
    Jeannon, JP
    Soames, J
    Lunec, J
    Awwad, S
    Ashton, V
    Wilson, JA
    [J]. CLINICAL OTOLARYNGOLOGY, 2000, 25 (01): : 23 - 27
  • [27] Jin YT, 1998, CANCER, V82, P2159, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2159::AID-CNCR10>3.0.CO
  • [28] 2-T
  • [29] Kitada S, 1996, ONCOGENE, V12, P187
  • [30] p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma
    Koch, WM
    Brennan, JA
    Zahurak, M
    Goodman, SN
    Westra, WH
    Schwab, D
    Yoo, GH
    Lee, DJ
    Forastiere, AA
    Sidransky, D
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21): : 1580 - 1586